FDA Approved: STIOLTO RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved STIOLTO RESPIMAT (tiotropium bromide and olodaterol) as an original application for the maintenance treatment of chronic obstructive pulmonary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Stiolto Respimat (tiotropium + olodaterol)

Snippet

ORIG AP for STIOLTO RESPIMAT (TIOTROPIUM BROMIDE AND OLODATEROL)